Mileen Vasudeo says: “I am recommending two stocks here. One is Zydus Life which last time I had seen at Rs 730. Keep a stop loss of Rs 685, target would be Rs 769-797 levels. The second stock is by Divis Lab, currently trading at Rs 5,922. One can keep a stop loss of Rs 5,800 on the higher side. Yes, Rs 6,114-6,240 could be possible.”
Motilal Oswal is bullish on Lemon Tree recommended buy rating on the stock with a target price of Rs 150 in its research report dated January 02, 2024.
The target upgrade in Lemon Tree comes on the back of the company signing a franchise agreement for an upcoming hotel in Mussoorie, Uttarakhand. This opening will be in addition to its eight existing and seven upcoming hotels & resorts in the state, the company filing of December 28 said.
Sanjiv Bhasin says: “Be cautious of some of the outstretched valuation and when you get these big brokerage calls of absurd returns, you should be selling. Right now, if I have comfort it is in some of the PSU oil marketing companies, some of the pharma names. And if you want I can suggest two names which I think can outperform from here.”